comprehensive -WSS

comprehensive

author：hotspot 2025-08-04 03:41:55 - browse：25591

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Infectious disease expert Jeanne Marrazzo assumes Fauci role

knowledge

WSS

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Genentech weighs delaying cancer therapy after drug pricing law

Faced with fears of OxyContin misuse, sales reps touted its safety

Newly revealed memo details efforts to keep Trump in power following election loss

Maui funeral service workers on devastation of fires: 'I'm in shock'

Timeline: Special counsel's investigation into Trump's handling of classified documents

hotspot

comprehensive

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

An innovative path out of biotech’s “valley of death”

Jerome Adams on the need for new antivirals for Covid

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Medical leaders decry Supreme Court decision on affirmative action

TB outbreak tied to bone grafts underscores testing shortcomings

Continuity nursing helped my family in our darkest PICU moments

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Activists slam private health insurers over coverage restrictions

What to expect as Trump is arraigned on his Jan 6. indictment

focus

TB outbreak tied to bone grafts underscores testing shortcomings

Adults seen as increasingly susceptible to measles

Vertex non

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

TB outbreak tied to bone grafts underscores testing shortcomings

Vertex non

knowledge

leisure time

leisure time

explore